Benzinga
Benzinga
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Benzinga
domingo, octubre 25
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Incyte Corp
INCY
NASDAQ
Lista de seguimiento
Get Report
Trade with Public
Get Report
Trade with Public
$115.71
-1.22
-1.04%
Últ. Act.: Oct 23, 4:40 PM
Get Report
Panorámica general
Noticias
Previsión de beneficios
Eventos
Precios objetivo
Finanzas
Sentimiento
Propiedad
Comparar
Opciones
Informe de acciones
Ganancias:
Beneficios de Q3 2026 dentro de 4 días de ahora en jue oct 29th, antes de la apertura del mercado
Conferencia telefónica:
Conferencia telefónica programada para dentro de 4 días a las 8:00 a. m.
Haz clic para ver el webcast
Incyte Financials
Incyte (INCY) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
Incyte Analysts Raise Their Forecasts After Upbeat Q2 Results
Incyte Corp. (INCY) reported strong Q2 results, raised full-year sales guidance. CEO cites sales growth, pipeline progress, and business development. Analysts maintain buy ratings with price target increases.
Avi Kapoor
Incyte Says It's No Longer A One-Drug Story
Incyte (INCY) Q2 earnings beat estimates with $1.67B revenue, $3.09 EPS. Full-year sales guidance raised. Shares rally to new 52-week high.
Vandana Singh
PRO
Incyte Q2 Adj. EPS $3.09 Beats $2.12 Estimate, Sales $1.663B Beat $1.460B Estimate
Incyte (NASDAQ:INCY) reported quarterly earnings of $3.09 per share which beat the analyst consensus estimate of $2.12 by 45.75 percent. This is a 96.82 percent increase over earnings of $1.57 per share from the same
Benzinga Newsdesk
PRO
Incyte Raises FY2026 Sales Guidance from $4.770B-$4.940B to $5.130B-$5.260B vs $5.712B Est
Incyte (NASDAQ:INCY) raises FY2026 sales outlook from $4.770 billion-$4.940 billion to $5.130 billion-$5.260 billion vs $5.712 billion estimate.
Benzinga Newsdesk
PRO
Incyte Sees FY2026 Sales $4.770B-$4.940B vs $5.569B Est
Incyte (NASDAQ:INCY) sees FY2026 sales of $4.770 billion-$4.940 billion vs $5.569 billion analyst estimate.
Benzinga Newsdesk
PRO
CORRECTION: Incyte Q1 Adj. EPS $1.81 Beats $1.37 Estimate, Sales $1.273B Beat $1.217B Estimate.
Incyte (NASDAQ:INCY) reported quarterly earnings of $1.81 per share which beat the analyst consensus estimate of $1.37 by 32.12 percent. This is a 56.03 percent increase over earnings of $1.16 per share from the same
Benzinga Newsdesk
